{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:21Z","timestamp":1791308841178,"version":"4.3.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.vaccine.2012.09.010","type":"journal-article","created":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T18:03:43Z","timestamp":1349460223000},"page":"6851-6858","source":"Crossref","is-referenced-by-count":15,"title":["Plasma beads loaded with Candida albicans cytosolic proteins impart protection against the fungal infection in BALB\/c mice"],"prefix":"10.1016","volume":"30","author":[{"given":"Ejaj","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munazza T.","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Saleemuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Owais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2012.09.010_bib0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0966-842X(98)01218-9","article-title":"Candida albicans hyphal formation and virulence: is there a clearly defined role?","volume":"6","author":"Kobayashi","year":"1998","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2012.09.010_bib0010","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1371\/journal.ppat.0040035","article-title":"Mucosal damage and neutropenia are required for Candida albicans dissemination","volume":"4","author":"Koh","year":"2008","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.vaccine.2012.09.010_bib0015","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program","volume":"42","author":"Hajjeh","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2012.09.010_bib0020","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/archinte.1989.00390110097022","article-title":"Treatment of systemic fungal infections with liposomal amphotericin B","volume":"149","author":"Lopez-Berestein","year":"1989","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.vaccine.2012.09.010_bib0025","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1128\/JCM.41.12.5623-5632.2003","article-title":"Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4 year global evaluation using disk diffusion","volume":"41","author":"Hazen","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2012.09.010_bib0030","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1093\/clinids\/22.Supplement_2.S166","article-title":"The future of antifungal therapy","volume":"22","author":"Graybill","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2012.09.010_bib0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13693780500035979","article-title":"Is a vaccine needed against Candida albicans?","volume":"43","author":"Mochon","year":"2005","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.09.010_bib0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0195-6701(98)90242-0","article-title":"Yeast carriage on hands of hospital personnel working in intensive care units","volume":"39","author":"Huang","year":"1998","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.vaccine.2012.09.010_bib0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00437281","article-title":"Systemic candidiasis in mice immunized with Candida albicans ribosomes","volume":"91","author":"Levy","year":"1985","journal-title":"Mycopathologia"},{"issue":"12","key":"10.1016\/j.vaccine.2012.09.010_bib0050","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1128\/IAI.62.12.5353-5360.1994","article-title":"A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity cytokine production, and anticandidal protection in mice","volume":"62","author":"Mencacci","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.09.010_bib0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/AAC.44.2.243-247.2000","article-title":"Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections","volume":"44","author":"Mizutani","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.vaccine.2012.09.010_bib0060","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1128\/IAI.65.10.4100-4107.1997","article-title":"Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies","volume":"65","author":"Han","year":"1997","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2012.09.010_bib0065","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4155\/tde.11.30","article-title":"Beaded plasma clot: a potent sustained-release, drug-delivery system","volume":"2","author":"Ahmad","year":"2011","journal-title":"Therap Deliv"},{"issue":"46","key":"10.1016\/j.vaccine.2012.09.010_bib0070","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1016\/j.vaccine.2007.09.008","article-title":"Escheriosome-mediated delivery of recombinant ribosomal L7\/L12 protein confers protection against murine brucellosis","volume":"25","author":"Mallick","year":"2007","journal-title":"Vaccine"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2012.09.010_bib0075","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0264-410X(03)00106-3","article-title":"Antigen entrapped in the escheriosomes leads to the generation of CD4(+) helper and CD8(+) cytotoxic T cell response","volume":"21","author":"Syed","year":"2003","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2012.09.010_bib0080","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1046\/j.1432-1327.2000.01447.x","article-title":"Liposome-mediated cytosolic delivery of macromolecules and its possible use in vaccine development","volume":"267","author":"Owais","year":"2000","journal-title":"Eur J Biochem"},{"issue":"7","key":"10.1016\/j.vaccine.2012.09.010_bib0085","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1128\/IAI.61.7.2854-2865.1993","article-title":"Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response","volume":"61","author":"Buchanan","year":"1993","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2012.09.010_bib0090","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production","volume":"141","author":"Ding","year":"1988","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2012.09.010_bib0095","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1128\/IAI.61.10.4202-4207.1993","article-title":"Candida specific Th1 type responsiveness in mice with experimental vaginal candidiasis","volume":"61","author":"Fidel","year":"1993","journal-title":"Infect Immun"},{"issue":"36","key":"10.1016\/j.vaccine.2012.09.010_bib0100","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1073\/pnas.0803195105","article-title":"Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis","volume":"105","author":"Xin","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2012.09.010_bib0105","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1128\/IAI.63.7.2714-2719.1995","article-title":"Antibody response that protects against disseminated candidiasis","volume":"63","author":"Han","year":"1995","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2012.09.010_bib0110","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/infdis\/174.3.589","article-title":"B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis","volume":"174","author":"Wagner","year":"1996","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2012.09.010_bib0115","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/13693780500448230","article-title":"Feasibility and prospects for a vaccine to prevent cryptococcosis","volume":"43","author":"Casadevall","year":"2005","journal-title":"Med Mycol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.09.010_bib0120","first-page":"208","article-title":"Synthetic particulate antigen delivery systems for vaccination","volume":"24","author":"Espuelas","year":"2005","journal-title":"Immunologia"},{"issue":"7","key":"10.1016\/j.vaccine.2012.09.010_bib0125","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/js950377g","article-title":"Aqueous stability of recombinant human thrombopoietin as a function of processing schemes","volume":"85","author":"Senderoff","year":"1996","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2012.09.010_bib0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425247.2011.558081","article-title":"Liposomal vaccine delivery systems","volume":"8","author":"Henriksen-Lacey","year":"2011","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.vaccine.2012.09.010_bib0135","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.iy.12.040194.003223","article-title":"Acquisation of lymphokine producing phenotype by CD4+ T cells","volume":"12","author":"Seder","year":"1994","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2012.09.010_bib0140","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1517\/14712598.6.9.891","article-title":"Host defense against disseminated Candida albicans infection and implications for antifungal immunotherapy","volume":"6","author":"Vonk","year":"2006","journal-title":"Expert Opin Biol Ther"},{"issue":"6174","key":"10.1016\/j.vaccine.2012.09.010_bib0145","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/333664a0","article-title":"Vascular endothelial cells synthesize nitric oxide from l-arginine","volume":"333","author":"Palmer","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2012.09.010_bib0155","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.4049\/jimmunol.163.8.4175","article-title":"Integrating signals from IFN-\u03b3 and IL-4 by B cells: positive and negative effects on CD40 ligand-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE, and IgG2a","volume":"163","author":"Hasbold","year":"1999","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.09.010_bib0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jlb.55.1.35","article-title":"The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection","volume":"55","author":"Huffnagle","year":"1994","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2012.09.010_bib0160","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-2249.1998.00724.x","article-title":"Differential regulation of Th1 and Th2 cells by p 91\u2013110 and p 21\u201340 peptides of the 16-kD alpha-crystallin antigen of Mycobacterium tuberculosis","volume":"114","author":"Agrewala","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2012.09.010_bib0165","first-page":"59","article-title":"Antigen incorporation into liposomes results in the enhancement of IL-4 and IgG1 secretion: evidence for preferential expansion of Th-2 cells","volume":"2","author":"Agrewala","year":"1996","journal-title":"Cytokines Mol Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2012.09.010_bib0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1084\/jem.20021542","article-title":"Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation","volume":"198","author":"Delamarre","year":"2003","journal-title":"J Exp Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12013205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12013205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T01:46:35Z","timestamp":1714441595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12013205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":34,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0264410X12013205"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.09.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}